Air pollution has long been treated as a lung problem. A growing body of evidence says that view is too narrow. A large cardiac imaging study now adds weight to a more unsettling message — the air people breathe for years may leave a visible mark on the arteries that supply the heart, even when pollution levels are considered moderate by current standards.
The study, published in Radiology, examined more than 11,000 adults who underwent cardiac CT scans across three major hospitals in Toronto between 2012 and 2023. Researchers linked each patient’s residential postal code with air quality data, then estimated average exposure to two common urban pollutants over the preceding 10 years: fine particulate matter, known as PM2.5, and nitrogen dioxide, or NO2.
The results were striking. Higher long-term exposure to PM2.5 was associated with more coronary artery calcium, greater total plaque burden, and higher odds of obstructive coronary artery disease. In plain terms, people exposed to more fine particle pollution were more likely to show signs of hardened, narrowed, plaque-filled heart arteries on CT imaging.
The signal appeared at exposure levels typical of many high-income urban settings. That is what makes the findings especially important. This was not a study of extreme smog, industrial disaster, or heavily polluted megacities. The median 10-year PM2.5 exposure in the study population was reported to be well below the current Canadian Ambient Air Quality Standard. Yet measurable differences in coronary atherosclerosis still appeared.
Coronary atherosclerosis is the slow build-up of fatty, calcified, inflammatory plaque inside the arteries that feed the heart muscle. It can develop silently over decades. Some people feel nothing until a plaque ruptures, a clot forms, or an artery becomes severely narrowed. That may lead to angina, heart attack, heart failure, or sudden death.
Cardiac CT offers a direct look at this process. A calcium score scan measures calcified plaque in the coronary arteries. CT angiography can go further, showing both calcified and non-calcified plaque, total plaque burden, and whether a narrowing is severe enough to restrict blood flow. This is one reason the new study stands out. It did not rely only on hospital admissions, death records, or broad population estimates. It used imaging evidence of disease inside the arteries.
According to the research, every increase of 1 microgram per cubic metre in long-term PM2.5 exposure was linked with an 11% increase in coronary artery calcium, 13% greater odds of higher plaque burden, and 23% greater odds of obstructive disease. Nitrogen dioxide exposure showed similar patterns, though the effect sizes were smaller for each 1 part-per-billion increase.
Those figures should not be read as proof that pollution alone caused disease in any one patient. The study was observational. It can show association, not absolute cause and effect.
Still, the findings remained meaningful after researchers accounted for traditional cardiovascular risk factors. That matters. Age, smoking, high blood pressure, diabetes, cholesterol, body weight, medication use, and other clinical variables are central to heart risk. Air pollution now appears to belong in that same conversation.
The World Health Organization identifies air pollution as the leading environmental risk factor for cardiovascular disease worldwide. It contributes to roughly 2.5 million cardiovascular deaths each year. The main concern is no longer only wheezing, asthma, or chronic bronchitis. The heart, brain, blood vessels, kidneys, and metabolic system are also affected.
PM2.5 is especially harmful because of its size. These particles measure 2.5 micrometres or less in diameter, around 30 times smaller than the width of a human hair. They come from vehicle exhaust, industrial emissions, power generation, wood burning, wildfire smoke, construction activity, and other combustion sources. Once inhaled, they can travel deep into the lungs. Some particles, or the inflammatory chemicals they trigger, can influence the bloodstream.
Scientists believe PM2.5 may promote cardiovascular damage through several overlapping pathways. It can increase inflammation, oxidative stress, blood clotting tendency, endothelial dysfunction, autonomic imbalance, and blood pressure. Over time, these biological changes may accelerate plaque formation, plaque instability, and arterial narrowing. The process is subtle. It is also persistent.
Nitrogen dioxide has a different profile, though it often shares sources with PM2.5. NO2 is produced mainly by burning fossil fuels, particularly from traffic, power plants, and industrial activity. In cities, road transport is a major contributor. NO2 can irritate the airways, worsen respiratory disease, and serve as a marker of traffic-related pollution. In cardiovascular research, it often tracks with a broader mixture of harmful pollutants.
The Toronto study adds new imaging-based evidence to a field already shaped by earlier findings. Previous research has linked short-term pollution spikes, over hours or days, with increased emergency visits for ischaemic heart disease, more hospital admissions for heart failure, and greater use of medical imaging. Longer-term exposure, over months or years, has been associated with higher risks of myocardial infarction, stroke, and cardiovascular death.
What this new work contributes is a closer view of the disease pathway before a major event occurs. Instead of waiting until people have heart attacks or strokes, cardiac CT can reveal the arterial changes that make those events more likely. That is clinically valuable. Prevention depends on recognising risk early.
The study also raises a difficult policy question. If measurable coronary artery disease is associated with air pollution levels near or below current regulatory limits, are those limits protective enough? Researchers involved in the work suggest the answer may be no. They argue there may be no clear safe threshold for cardiovascular harm from air pollution. That does not mean every exposure has the same impact. It means risk may decline as pollution falls, without a neat line below which harm disappears.
For clinicians, the findings may encourage a broader approach to cardiovascular risk assessment. Doctors already ask about smoking, blood pressure, cholesterol, diabetes, family history, diet, exercise, and symptoms. Environmental exposure is less commonly discussed in routine appointments. That may change. A patient living for decades beside a congested motorway, industrial corridor, wildfire-prone region, or poorly ventilated urban area may carry a risk that is not fully captured by standard calculators.
For patients, the message should be practical rather than frightening. No one can control the entire air shed around them. Many exposure risks are shaped by income, housing, occupation, transport systems, urban design, and public policy. Still, some personal steps may reduce exposure.
People can monitor local air quality reports, especially during wildfire smoke events or high-pollution days. Outdoor exercise can be shifted away from busy roads where possible. Home filtration may help, particularly high-efficiency particulate air filtration in rooms used most often. Keeping windows closed during smoke events, avoiding indoor burning, improving ventilation during cooking, and using recirculation mode in traffic may reduce particle exposure. Those with known heart disease, older adults, pregnant people, and individuals with respiratory conditions may need extra caution during pollution peaks.
Yet personal action has limits. The larger health gains come from cleaner transport, tighter industrial controls, cleaner power generation, low-emission zones, better urban planning, more green space, wildfire mitigation, and reduced fossil fuel combustion. Air quality policy is heart disease prevention. It is also climate policy.
That link between air pollution and climate change is not theoretical. Fossil fuel combustion drives both greenhouse gas emissions and much of the air pollution that harms cardiovascular health. Measures that cut fossil fuel use can therefore produce rapid local health benefits, sometimes within months, while also supporting longer-term climate goals. Fewer combustion emissions mean fewer fine particles, less nitrogen dioxide, cleaner urban air, and potentially fewer heart attacks.
The study population deserves careful interpretation. These were adults who had cardiac CT examinations, not a random sample of the general public. Some may have had symptoms, risk factors, or clinical reasons for imaging. Residential postal codes are useful for estimating exposure, though they cannot perfectly capture where people work, commute, exercise, or spend time indoors. Air pollution mixtures are complex. PM2.5 and NO2 are important markers, not the whole story. Other pollutants, noise, neighbourhood deprivation, heat exposure, access to care, and lifestyle factors may also shape risk.
Even with those caveats, the scale of the study strengthens its relevance. More than 11,000 cardiac CT examinations provide a substantial dataset. The 10-year exposure window also fits the biology of atherosclerosis, which develops gradually. The use of calcium score, total plaque burden, and obstructive stenosis gives a more complete picture than calcium scoring alone.
The public health implications are broad. Coronary artery disease remains one of the world’s leading killers. Traditional prevention has focused, rightly, on smoking cessation, blood pressure control, cholesterol lowering, diabetes care, exercise, diet, and medication when needed. This study suggests cleaner air should sit beside those interventions, not outside them.
The idea is simple. The arteries do not exist apart from the environment. They respond to what enters the body, day after day, breath after breat
Clean air is often discussed as an environmental ideal. This research frames it as something more immediate — a “cardiovascular treatment” delivered at population scale.
The post Exposure to Even Moderately Polluted Air Is Linked to Heart Damage, Study Shows first appeared on PP Health Malaysia.
